Shopping Cart
- Remove All
- Your shopping cart is currently empty
VPC-13163 (NSC-52361) has strong anti-proliferative activity against LNCaP and Enzalutamide-resistant prostate cancer cell lines (MR49F) whereas it did not affect the growth of AR independent PC3 cell line. It also inhibits Prostate Specific Antigen (PSA) in both LNCaP and MR49F and reduces expression of AR target genes, PSA and TMPRSS2. These findings suggest that VPC-13566 exhibits AR BF3 specific mechanism of action.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $82 | In Stock | |
2 mg | $119 | In Stock | |
5 mg | $197 | In Stock | |
10 mg | $298 | In Stock | |
25 mg | $476 | In Stock | |
50 mg | $678 | In Stock | |
100 mg | $912 | In Stock | |
200 mg | $1,190 | In Stock | |
1 mL x 10 mM (in DMSO) | $177 | In Stock |
Description | VPC-13163 (NSC-52361) has strong anti-proliferative activity against LNCaP and Enzalutamide-resistant prostate cancer cell lines (MR49F) whereas it did not affect the growth of AR independent PC3 cell line. It also inhibits Prostate Specific Antigen (PSA) in both LNCaP and MR49F and reduces expression of AR target genes, PSA and TMPRSS2. These findings suggest that VPC-13566 exhibits AR BF3 specific mechanism of action. |
Alias | VPC13163, VPC 13163, NSC52361, NSC 52361, 2,3-dihydro-2,3'-Bi-1H-indole |
Molecular Weight | 234.3 |
Formula | C16H14N2 |
Cas No. | 6637-10-1 |
Smiles | C=1(C=2C(NC1)=CC=CC2)C3CC=4C(N3)=CC=CC4 |
Relative Density. | 1.225g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 65 mg/ml (277.42 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.